JP2013525440A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525440A5 JP2013525440A5 JP2013508147A JP2013508147A JP2013525440A5 JP 2013525440 A5 JP2013525440 A5 JP 2013525440A5 JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013508147 A JP2013508147 A JP 2013508147A JP 2013525440 A5 JP2013525440 A5 JP 2013525440A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- effective amount
- therapeutically effective
- day
- balsalazide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 claims description 29
- 229960004168 balsalazide Drugs 0.000 claims description 29
- 239000003826 tablet Substances 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 16
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 12
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 12
- 238000009472 formulation Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000007941 film coated tablet Substances 0.000 claims description 8
- 230000035876 healing Effects 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 4
- 206010038063 Rectal haemorrhage Diseases 0.000 claims description 4
- 208000010643 digestive system disease Diseases 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 3
- 235000012631 food intake Nutrition 0.000 claims description 3
- 208000018685 gastrointestinal system disease Diseases 0.000 claims description 3
- 230000013872 defecation Effects 0.000 claims description 2
- 238000001839 endoscopy Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 35
- 238000002579 sigmoidoscopy Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 35
- 238000002052 colonoscopy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32815110P | 2010-04-26 | 2010-04-26 | |
| US61/328,151 | 2010-04-26 | ||
| PCT/US2011/033905 WO2011137103A1 (en) | 2010-04-26 | 2011-04-26 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525440A JP2013525440A (ja) | 2013-06-20 |
| JP2013525440A5 true JP2013525440A5 (enExample) | 2014-06-19 |
Family
ID=44861888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508147A Pending JP2013525440A (ja) | 2010-04-26 | 2011-04-26 | 男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8497256B2 (enExample) |
| EP (1) | EP2563117B1 (enExample) |
| JP (1) | JP2013525440A (enExample) |
| AU (1) | AU2011245455A1 (enExample) |
| BR (2) | BR112012027520A2 (enExample) |
| CA (1) | CA2797560A1 (enExample) |
| IL (1) | IL222642A0 (enExample) |
| MX (1) | MX358142B (enExample) |
| WO (1) | WO2011137103A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019236772A1 (en) | 2018-06-05 | 2019-12-12 | Flagship Pioneering Innovations V, Inc. | Acylated active agents and methods of their use for the treatment of autoimmune disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US326364A (en) | 1885-09-15 | Electric-lamp hanger | ||
| US4298595A (en) | 1978-12-20 | 1981-11-03 | Dynapol | Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract |
| US5196205A (en) | 1987-10-12 | 1993-03-23 | Borody Thomas J | Method for treatment of gastro intestinal disorders |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5498608A (en) | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| US5905073A (en) | 1995-01-06 | 1999-05-18 | Salix Pharmaceuticals, Inc. | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| SE9700934D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | New formulation |
| SI0971735T1 (sl) | 1997-04-01 | 2008-08-31 | Borody Thomas J | Postopek in sestavina za zdravljenje bolezni vnetja debelega äśrevesa |
| US6551632B2 (en) | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
| AUPP437698A0 (en) | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
| US6326364B1 (en) | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| CN102670626A (zh) * | 2005-08-24 | 2012-09-19 | 萨利克斯药品公司 | 巴柳氮制剂及其生产和应用 |
| US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| US7452872B2 (en) * | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| US20100048519A1 (en) | 2006-09-13 | 2010-02-25 | Chyon-Hwa Yeh | Methods of treatment for ulcerative colitis using aminosalicylate |
-
2011
- 2011-04-26 BR BR112012027520A patent/BR112012027520A2/pt not_active IP Right Cessation
- 2011-04-26 MX MX2012012324A patent/MX358142B/es active IP Right Grant
- 2011-04-26 US US13/094,261 patent/US8497256B2/en active Active
- 2011-04-26 JP JP2013508147A patent/JP2013525440A/ja active Pending
- 2011-04-26 BR BR122014009845A patent/BR122014009845A2/pt not_active Application Discontinuation
- 2011-04-26 EP EP11775497.8A patent/EP2563117B1/en active Active
- 2011-04-26 AU AU2011245455A patent/AU2011245455A1/en not_active Abandoned
- 2011-04-26 WO PCT/US2011/033905 patent/WO2011137103A1/en not_active Ceased
- 2011-04-26 CA CA2797560A patent/CA2797560A1/en not_active Withdrawn
-
2012
- 2012-10-23 IL IL222642A patent/IL222642A0/en unknown
-
2013
- 2013-07-10 US US13/938,777 patent/US20130295178A1/en not_active Abandoned
-
2014
- 2014-10-08 US US14/509,446 patent/US20150132381A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527092A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| FI3936130T3 (fi) | Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon | |
| JP2019525944A5 (enExample) | ||
| JP2014526503A5 (enExample) | ||
| JP2015522630A5 (enExample) | ||
| JP2012082215A5 (enExample) | ||
| JP2012520866A5 (enExample) | ||
| JP2012533565A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| RU2018136872A (ru) | Композиции, содержащие 15-oh эпк, и способы их применения | |
| WO2015034678A3 (en) | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis | |
| JP2009501801A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| JP2016507500A5 (enExample) | ||
| JP2008533127A5 (enExample) | ||
| JP2017514858A5 (enExample) | ||
| JP2012505830A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
| HRP20190211T1 (hr) | Inhibitor proteina za prijenos kolesterilestera (cetp) i farmaceutski pripravci koji sadrže spomenuti inhibitor za primjenu u liječenju ili prevenciji kardiovaskularnih bolesti | |
| JP2012041314A5 (enExample) | ||
| RU2016144695A (ru) | Комплекс танната ситаглиптина |